It has been confirmed that CHOP chemoresistance is mainly associated with the upregulation of anti-apoptotic and pro-survival (Bcl-2 family, Bcl-XL, BCR signaling, and IAPs) signaling pathways in DLBCL [11,42]. This evidence concerns the gene BCL2L1 and diffuse large B-cell lymphoma.